Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

NCT01521559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

PROCEDURE: Macular Laser Photocoagulation
DRUG: Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]